Vascular Brain Accident - Development of methods and tools for continuous EEG monitoring in Intensive Care Units in case of vascular brain accidents.
From 01-04-2013 to 31-03-2019
Description
The project objectives are:
1. Develop new methods of detection and suppression of artifacts that allows the use of reliable EEG signal in cerebral functional status assessment for acute stroke.
2. Improve procedures for detection of spikes and epileptiform discharges during acute stroke.
3. Develop methods for classifying EEG in real time to determine the level of consciousness (waking vs. coma) in patients with acute stroke.
4. Implement methods of EEG analysis to estimate the level of FSC for acute ischemic stroke and determine the feasibility of application of thrombolytic treatment.
5. Design a prototype monitor brain function from determining quantitative EEG parameters, to assess directly the brain response to arterial revascularization procedures and other therapeutic actions.
6. Investigate the feasibility of classification of clinical forms of stroke (ischemic vs hemorrhagic) from EEG signal parameters.
7. To Increase the number and the quality of the professionals on the eastern region of Cuba dedicated to biomedical signal processing (PhD, MSc, and Bachelors).
8. To create a research laboratory / classroom to support the Biomedical Engineering PhD and Master programs, in the Electrical Engineering Faculty and in the Juan Bruno Zayas Hospital *. To support Together With The professors of Catholic University of Leuven, the PhD and MSc programs in Biomedical Engineering in Universidad de Oriente, Cuba.
9. Assimilate new research topics and new ideas, from Belgium counterpart.
Team
- Daniel Escobedo Beceiro, Co-promoter (External)
- Sabine Van Huffel, Promoter
- Enrique Juan Marañón Reyes, Promoter
- Steven Vandeput, Team member
Financing
Funding: -
Program/Grant Type: VLIR UOS Project - VLIR UOS Project
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.